{"id":733,"date":"2021-08-24T05:40:12","date_gmt":"2021-08-24T12:40:12","guid":{"rendered":"https:\/\/shapememordev.wpenginepowered.com\/row\/?p=733"},"modified":"2022-12-20T16:45:50","modified_gmt":"2022-12-21T00:45:50","slug":"shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2","status":"publish","type":"post","link":"https:\/\/www.shapemem.com\/row\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\/","title":{"rendered":"Shape Memory Medical Announces First Patient Enrollment in the AAA-SHAPE Netherlands Study"},"content":{"rendered":"

[vc_row nav_skin=”light” consent_include=”include”][vc_column css_animation=””][vc_text_element css_animation=””]<\/p>\n

\n

August 24, 2021 10:00 AM Eastern Daylight Time<\/span><\/h1>\n<\/header>\n
\n
\n

SANTA CLARA, Calif.–(BUSINESS WIRE<\/a>)–Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced the initiation of AAA-SHAPE Netherlands, the Company\u2019s prospective, multicenter early feasibility study of the IMPEDE-FX RapidFill\u00ae Device when used for abdominal aortic aneurysm (AAA) sac management during elective endovascular aneurysm repair (EVAR). The Dutch study\u2019s first procedure was performed by Professor Michel Reijnen, MD, PhD, vascular surgeon at Rijnstate Hospital in Arnhem, the Netherlands.<\/p>\n

Ted Ruppel, President and Chief Executive Officer of Shape Memory Medical Inc. said, “We would like to congratulate Professor Reijnen and the clinical study team at Rijnstate Hospital for a successful first AAA-SHAPE case in the Netherlands. The addition of Dutch sites to the AAA-SHAPE program accelerates our ability to evaluate IMPEDE-FX RapidFill and its potential to improve sac regression in AAA patients following EVAR.\u201d The study will enroll up to 15 patients across three centers in the Netherlands, contributing to the AAA-SHAPE safety study which is also currently enrolling up to 15 patients in Auckland, New Zealand.<\/p>\n

The IMPEDE-FX RapidFill Device contains five IMPEDE-FX, 12mm embolization plugs preloaded into a single delivery introducer for fast and efficient delivery of the embolic material. This high volume platform incorporates the novel Shape Memory Polymer, a porous, embolic scaffold that is crimped for catheter delivery and self-expands upon contact with blood for rapid conversion to organized thrombus. Pre-clinical and clinical studies have shown that Shape Memory Polymer offers effective and predictable space filling, stable clot formation for sac embolization, and progressive healing as the material biodegrades.<\/p>\n

\u201cWe are excited to contribute to AAA-SHAPE,\u201d said Professor Reijnen, principal investigator for AAA-SHAPE Netherlands. \u201cPatients who develop aneurysm sac shrinkage following EVAR have better outcomes than patients with a stable or growing aneurysm sac. We look forward to learning how the use of IMPEDE-FX RapidFIll in combination with EVAR influences sac behavior,\u201d continued Reijnen.<\/p>\n

\u201cWe are very pleased to be working together with colleagues from the Netherlands to add to our growing experience with AAA-SHAPE,\u201d said Andrew Holden, MBChB, interventional radiologist at Auckland City Hospital. \u201cOur preliminary experience with AAA-SHAPE has been very encouraging, and the first few patients have shown a reduction in AAA sac diameter at early follow-up,\u201d continued Holden.<\/p>\n

About Shape Memory Medical<\/b><\/p>\n

Shape Memory Medical Inc. is dedicated to developing innovative therapeutic solutions with its proprietary shape memory polymers. Neurovascular embolization products include the TrelliX\u00ae Embolic Coil, which is CE marked for use in the EU. Peripheral embolization products include the IMPEDE\u00ae and IMPEDE-FX Embolization Plugs and IMPEDE-FX RapidFill\u00ae Device. In countries recognizing CE marking, the IMPEDE and IMPEDE-FX Embolization Plugs and the IMPEDE-FX RapidFill are indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. In the United States, the IMPEDE Embolization Plug is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature, and the IMPEDE-FX Embolization Plug is indicated for use with the IMPEDE Embolization Plug to obstruct or reduce the rate of blood flow in the peripheral vasculature. The IMPEDE and IMPEDE-FX Embolization Plugs are PMDA approved in Japan. For more information, visit\u00a0www.shapemem.com<\/a>.<\/p>\n

\"\"<\/p>\n<\/div>\n

\n

Contacts<\/h2>\n

Mary Dennehy
\nm.dennehy@www.shapemem.com<\/a>
\n602-908-9812<\/p>\n<\/div>\n<\/div>\n

[\/vc_text_element][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced the initiation of AAA-SHAPE Netherlands, the Company\u2019s prospective, multicenter early feasibility study of the IMPEDE-FX RapidFill\u00ae Device when used for abdominal aortic aneurysm (AAA) sac management during elective endovascular aneurysm repair (EVAR). <\/p>\n","protected":false},"author":6,"featured_media":731,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[8],"tags":[],"class_list":["post-733","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-releases"],"acf":[],"yoast_head":"\nFirst Patient Enrollment in the AAA-SHAPE Netherlands Study<\/title>\n<meta name=\"description\" content=\"Peripheral embolization products include the IMPEDE\u00ae and IMPEDE-FX Embolization Plugs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.shapemem.com\/row\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First Patient Enrollment in the AAA-SHAPE Netherlands Study\" \/>\n<meta property=\"og:description\" content=\"Peripheral embolization products include the IMPEDE\u00ae and IMPEDE-FX Embolization Plugs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.shapemem.com\/row\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Shape Memory Medical - RoW\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-24T12:40:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-12-21T00:45:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.shapemem.com\/row\/wp-content\/uploads\/sites\/12\/2022\/04\/Rectangle-22.png\" \/>\n\t<meta property=\"og:image:width\" content=\"507\" \/>\n\t<meta property=\"og:image:height\" content=\"321\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jason Rutten\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jason Rutten\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\\\/\"},\"author\":{\"name\":\"Jason Rutten\",\"@id\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/#\\\/schema\\\/person\\\/9cb5c79a564e0f091950bf3109a2b2be\"},\"headline\":\"Shape Memory Medical Announces First Patient Enrollment in the AAA-SHAPE Netherlands Study\",\"datePublished\":\"2021-08-24T12:40:12+00:00\",\"dateModified\":\"2022-12-21T00:45:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\\\/\"},\"wordCount\":572,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/wp-content\\\/uploads\\\/sites\\\/12\\\/2022\\\/04\\\/Rectangle-22.png\",\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\\\/\",\"url\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\\\/\",\"name\":\"First Patient Enrollment in the AAA-SHAPE Netherlands Study\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/wp-content\\\/uploads\\\/sites\\\/12\\\/2022\\\/04\\\/Rectangle-22.png\",\"datePublished\":\"2021-08-24T12:40:12+00:00\",\"dateModified\":\"2022-12-21T00:45:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/#\\\/schema\\\/person\\\/9cb5c79a564e0f091950bf3109a2b2be\"},\"description\":\"Peripheral embolization products include the IMPEDE\u00ae and IMPEDE-FX Embolization Plugs.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.shapemem.com\\\/row\\\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/wp-content\\\/uploads\\\/sites\\\/12\\\/2022\\\/04\\\/Rectangle-22.png\",\"contentUrl\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/wp-content\\\/uploads\\\/sites\\\/12\\\/2022\\\/04\\\/Rectangle-22.png\",\"width\":507,\"height\":321},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shape Memory Medical Announces First Patient Enrollment in the AAA-SHAPE Netherlands Study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/#website\",\"url\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/\",\"name\":\"Shape Memory Medical - RoW\",\"description\":\"Smart Choice\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/#\\\/schema\\\/person\\\/9cb5c79a564e0f091950bf3109a2b2be\",\"name\":\"Jason Rutten\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5323b9b50a8e512897e57c3d998fe8a05d1a0dcd44c7eff22aaad4136eab1c60?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5323b9b50a8e512897e57c3d998fe8a05d1a0dcd44c7eff22aaad4136eab1c60?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5323b9b50a8e512897e57c3d998fe8a05d1a0dcd44c7eff22aaad4136eab1c60?s=96&d=mm&r=g\",\"caption\":\"Jason Rutten\"},\"url\":\"https:\\\/\\\/www.shapemem.com\\\/row\\\/author\\\/jasondigitalmarvel-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"First Patient Enrollment in the AAA-SHAPE Netherlands Study","description":"Peripheral embolization products include the IMPEDE\u00ae and IMPEDE-FX Embolization Plugs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.shapemem.com\/row\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\/","og_locale":"en_US","og_type":"article","og_title":"First Patient Enrollment in the AAA-SHAPE Netherlands Study","og_description":"Peripheral embolization products include the IMPEDE\u00ae and IMPEDE-FX Embolization Plugs.","og_url":"https:\/\/www.shapemem.com\/row\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\/","og_site_name":"Shape Memory Medical - RoW","article_published_time":"2021-08-24T12:40:12+00:00","article_modified_time":"2022-12-21T00:45:50+00:00","og_image":[{"width":507,"height":321,"url":"https:\/\/www.shapemem.com\/row\/wp-content\/uploads\/sites\/12\/2022\/04\/Rectangle-22.png","type":"image\/png"}],"author":"Jason Rutten","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jason Rutten","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.shapemem.com\/row\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\/#article","isPartOf":{"@id":"https:\/\/www.shapemem.com\/row\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\/"},"author":{"name":"Jason Rutten","@id":"https:\/\/www.shapemem.com\/row\/#\/schema\/person\/9cb5c79a564e0f091950bf3109a2b2be"},"headline":"Shape Memory Medical Announces First Patient Enrollment in the AAA-SHAPE Netherlands Study","datePublished":"2021-08-24T12:40:12+00:00","dateModified":"2022-12-21T00:45:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.shapemem.com\/row\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\/"},"wordCount":572,"commentCount":0,"image":{"@id":"https:\/\/www.shapemem.com\/row\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.shapemem.com\/row\/wp-content\/uploads\/sites\/12\/2022\/04\/Rectangle-22.png","articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.shapemem.com\/row\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\/","url":"https:\/\/www.shapemem.com\/row\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\/","name":"First Patient Enrollment in the AAA-SHAPE Netherlands Study","isPartOf":{"@id":"https:\/\/www.shapemem.com\/row\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.shapemem.com\/row\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\/#primaryimage"},"image":{"@id":"https:\/\/www.shapemem.com\/row\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.shapemem.com\/row\/wp-content\/uploads\/sites\/12\/2022\/04\/Rectangle-22.png","datePublished":"2021-08-24T12:40:12+00:00","dateModified":"2022-12-21T00:45:50+00:00","author":{"@id":"https:\/\/www.shapemem.com\/row\/#\/schema\/person\/9cb5c79a564e0f091950bf3109a2b2be"},"description":"Peripheral embolization products include the IMPEDE\u00ae and IMPEDE-FX Embolization Plugs.","breadcrumb":{"@id":"https:\/\/www.shapemem.com\/row\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.shapemem.com\/row\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.shapemem.com\/row\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\/#primaryimage","url":"https:\/\/www.shapemem.com\/row\/wp-content\/uploads\/sites\/12\/2022\/04\/Rectangle-22.png","contentUrl":"https:\/\/www.shapemem.com\/row\/wp-content\/uploads\/sites\/12\/2022\/04\/Rectangle-22.png","width":507,"height":321},{"@type":"BreadcrumbList","@id":"https:\/\/www.shapemem.com\/row\/shape-memory-medical-announces-first-patient-enrollment-in-the-aaa-shape-netherlands-study-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.shapemem.com\/row\/"},{"@type":"ListItem","position":2,"name":"Shape Memory Medical Announces First Patient Enrollment in the AAA-SHAPE Netherlands Study"}]},{"@type":"WebSite","@id":"https:\/\/www.shapemem.com\/row\/#website","url":"https:\/\/www.shapemem.com\/row\/","name":"Shape Memory Medical - RoW","description":"Smart Choice","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.shapemem.com\/row\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.shapemem.com\/row\/#\/schema\/person\/9cb5c79a564e0f091950bf3109a2b2be","name":"Jason Rutten","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/5323b9b50a8e512897e57c3d998fe8a05d1a0dcd44c7eff22aaad4136eab1c60?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/5323b9b50a8e512897e57c3d998fe8a05d1a0dcd44c7eff22aaad4136eab1c60?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5323b9b50a8e512897e57c3d998fe8a05d1a0dcd44c7eff22aaad4136eab1c60?s=96&d=mm&r=g","caption":"Jason Rutten"},"url":"https:\/\/www.shapemem.com\/row\/author\/jasondigitalmarvel-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.shapemem.com\/row\/wp-json\/wp\/v2\/posts\/733","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.shapemem.com\/row\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.shapemem.com\/row\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.shapemem.com\/row\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.shapemem.com\/row\/wp-json\/wp\/v2\/comments?post=733"}],"version-history":[{"count":0,"href":"https:\/\/www.shapemem.com\/row\/wp-json\/wp\/v2\/posts\/733\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.shapemem.com\/row\/wp-json\/wp\/v2\/media\/731"}],"wp:attachment":[{"href":"https:\/\/www.shapemem.com\/row\/wp-json\/wp\/v2\/media?parent=733"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.shapemem.com\/row\/wp-json\/wp\/v2\/categories?post=733"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.shapemem.com\/row\/wp-json\/wp\/v2\/tags?post=733"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}